171 related articles for article (PubMed ID: 26035340)
1. Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization.
Basavarajappa HD; Lee B; Lee H; Sulaiman RS; An H; Magaña C; Shadmand M; Vayl A; Rajashekhar G; Kim EY; Suh YG; Lee K; Seo SY; Corson TW
J Med Chem; 2015 Jun; 58(12):5015-5027. PubMed ID: 26035340
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of photoaffinity probes of antiangiogenic homoisoflavonoids.
Lee B; Sun W; Lee H; Basavarajappa H; Sulaiman RS; Sishtla K; Fei X; Corson TW; Seo SY
Bioorg Med Chem Lett; 2016 Sep; 26(17):4277-81. PubMed ID: 27481561
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective Synthesis of Homoisoflavanones by Asymmetric Transfer Hydrogenation and Their Biological Evaluation for Antiangiogenic Activity.
Heo M; Lee B; Sishtla K; Fei X; Lee S; Park S; Yuan Y; Lee S; Kwon S; Lee J; Kim S; Corson TW; Seo SY
J Org Chem; 2019 Aug; 84(16):9995-10011. PubMed ID: 31381339
[TBL] [Abstract][Full Text] [Related]
4. The Antiangiogenic Activity of Naturally Occurring and Synthetic Homoisoflavonoids from the Hyacinthaceae ( sensu APGII).
Schwikkard S; Whitmore H; Sishtla K; Sulaiman RS; Shetty T; Basavarajappa HD; Waller C; Alqahtani A; Frankemoelle L; Chapman A; Crouch N; Wetschnig W; Knirsch W; Andriantiana J; Mas-Claret E; Langat MK; Mulholland D; Corson TW
J Nat Prod; 2019 May; 82(5):1227-1239. PubMed ID: 30951308
[TBL] [Abstract][Full Text] [Related]
5. microRNA-181a inhibits ocular neovascularization by interfering with vascular endothelial growth factor expression.
Yang C; Tahiri H; Cai C; Gu M; Gagnon C; Hardy P
Cardiovasc Ther; 2018 Jun; 36(3):e12329. PubMed ID: 29608244
[TBL] [Abstract][Full Text] [Related]
6. The first synthesis of the antiangiogenic homoisoflavanone, cremastranone.
Lee B; Basavarajappa HD; Sulaiman RS; Fei X; Seo SY; Corson TW
Org Biomol Chem; 2014 Oct; 12(39):7673-7. PubMed ID: 25167470
[TBL] [Abstract][Full Text] [Related]
7. Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21(WAF1) expression.
Kim JH; Lee BJ; Kim JH; Yu YS; Kim MY; Kim KW
Eur J Pharmacol; 2009 Aug; 615(1-3):150-4. PubMed ID: 19470386
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
[TBL] [Abstract][Full Text] [Related]
9. Suppression of retinal neovascularization by intravitreal injection of cryptotanshinone.
Yu Y; Qin X; Chen X; Nie H; Li J; Yao J
Biochem Biophys Res Commun; 2024 Aug; 720():150065. PubMed ID: 38749188
[TBL] [Abstract][Full Text] [Related]
10. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
[TBL] [Abstract][Full Text] [Related]
12. An arylidene-thiazolidinedione derivative, GPU-4, without PPARγ activation, reduces retinal neovascularization.
Nakamura S; Hayashi K; Takizawa H; Murase T; Tsuruma K; Shimazawa M; Kakuta H; Nagasawa H; Hara H
Curr Neurovasc Res; 2011 Feb; 8(1):25-34. PubMed ID: 21208163
[TBL] [Abstract][Full Text] [Related]
13. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
Bai YJ; Huang LZ; Xu XL; Du W; Zhou AY; Yu WZ; Li XX
J Pharmacol Exp Ther; 2012 Jul; 342(1):131-9. PubMed ID: 22495066
[TBL] [Abstract][Full Text] [Related]
14. Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy.
Lee YM; Lee YR; Kim CS; Jo K; Sohn E; Kim JS; Kim J
Int J Mol Sci; 2015 Dec; 16(12):29900-10. PubMed ID: 26694358
[TBL] [Abstract][Full Text] [Related]
15. Homoisoflavonoids as potential antiangiogenic agents for retinal neovascularization.
Amin SA; Adhikari N; Gayen S; Jha T
Biomed Pharmacother; 2017 Nov; 95():818-827. PubMed ID: 28892793
[TBL] [Abstract][Full Text] [Related]
16. Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization.
McAnally D; Siddiquee K; Gomaa A; Szabo A; Vasile S; Maloney PR; Divlianska DB; Peddibhotla S; Morfa CJ; Hershberger P; Falter R; Williamson R; Terry DB; Farjo R; Pinkerton AB; Qi X; Quigley J; Boulton ME; Grant MB; Smith LH
PLoS One; 2018; 13(9):e0202436. PubMed ID: 30208056
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
18. Tat PTD-Endostatin-RGD: A novel protein with anti-angiogenesis effect in retina via eye drops.
Li Y; Li L; Li Z; Sheng J; Zhang X; Feng D; Zhang X; Yin F; Wang A; Wang F
Biochim Biophys Acta; 2016 Oct; 1860(10):2137-47. PubMed ID: 27233450
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of choroidal neovascularization by homoisoflavanone, a new angiogenesis inhibitor.
Kim JH; Kim JH; Yu YS; Jun HO; Kwon HJ; Park KH; Kim KW
Mol Vis; 2008 Mar; 14():556-61. PubMed ID: 18385791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
